Fluorodeoxyglucose F18

solute carrier family 2 member 1 ; Homo sapiens







71 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31271267 [18F]fluorodeoxyglucose-positron emission tomography and glucose-transporter type 1 expression in untreated primary small bowel adenocarcinoma. 2021 Sep 1
2 32739099 Lenticular nuclei to thalamic ratio on PET is useful for diagnosis of GLUT1 deficiency syndrome. 2021 Jan 1
3 32886301 [18F]FDG Uptake in Adipose Tissue Is Not Related to Inflammation in Type 2 Diabetes Mellitus. 2021 Feb 1
4 33278334 Tyrosine Kinase Inhibitors Reduce Glucose Uptake by Binding to an Exofacial Site on hGLUT-1: Influence on 18 F-FDG PET Uptake. 2021 May 3
5 33725499 HRD1 attenuates the high uptake of [18F]FDG in hepatocellular carcinoma PET imaging. 2021 May-Jun 3
6 33750337 Correlation between glucose metabolism parameters derived from FDG and tumor TNM stages and metastasis-associated proteins in colorectal carcinoma patients. 2021 Mar 9 1
7 34049629 A GLUT1 inhibitor-based fluorogenic probe for Warburg effect-targeted drug screening and diagnostic imaging of hyperglycolytic cancers. 2021 Jul 4 1
8 34422129 18F-FDG PET/CT Evaluation of Thymomas: a Pictorial Review. 2021 Aug 1
9 34572860 Clinical Utility and Limitation of Diagnostic Ability for Different Degrees of Dysplasia of Intraductal Papillary Mucinous Neoplasms of the Pancreas Using 18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography. 2021 Sep 15 2
10 32028659 Prognostic Significance of Glucose Metabolism as GLUT1 in Patients with Pulmonary Pleomorphic Carcinoma. 2020 Feb 3 2
11 32269845 Establishment of a [18F]-FDG-PET/MRI Imaging Protocol for Gastric Cancer PDX as a Preclinical Research Tool. 2020 Mar 2
12 32626532 Overexpression of METTL3 associated with the metabolic status on 18F-FDG PET/CT in patients with Esophageal Carcinoma. 2020 2
13 30431083 EGFR mutation decreases FDG uptake in non‑small cell lung cancer via the NOX4/ROS/GLUT1 axis. 2019 Jan 1
14 30682160 In vivo positron emission tomographic blood pool imaging in an immunodeficient mouse model using 18F-fluorodeoxyglucose labeled human erythrocytes. 2019 2
15 30799682 PET Imaging of Hepatocellular Carcinomas: 18F-Fluoropropionic Acid as a Complementary Radiotracer for 18F-Fluorodeoxyglucose. 2019 Jan-Dec 1
16 31186081 ATAD2 expression increases [18F]Fluorodeoxyglucose uptake value in lung adenocarcinoma via AKT-GLUT1/HK2 pathway. 2019 Jul 1
17 29550845 Correlations between dual-phase 18F-FDG uptake and clinicopathologic and biological markers of breast cancer. 2018 Jan-Apr 1
18 29913554 Expression and function of hexose transporters GLUT1, GLUT2, and GLUT5 in breast cancer-effects of hypoxia. 2018 Sep 1
19 30083516 Evaluating Imaging Biomarkers of Acquired Resistance to Targeted EGFR Therapy in Xenograft Models of Human Head and Neck Squamous Cell Carcinoma. 2018 1
20 30864374 Sodium-glucose cotransporters: new targets of cancer therapy? 2018 Dec 1 2
21 28410229 In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CT. 2017 May 23 2
22 28412205 SLC2A1/GLUT1 expression in mural nodules of intraductal papillary mucinous neoplasm of the pancreas. 2017 Jul 4
23 28548087 The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition. 2017 May 26 1
24 27173341 Biological correlation between glucose transporters, Ki-67 and 2-deoxy-2-[18F]-fluoro-D-glucose uptake in diffuse large B-cell lymphoma and natural killer/T-cell lymphoma. 2016 May 9 1
25 27218430 Molecular biological correlation of fluorine-18 fluorodeoxyglucose uptake in esophageal squamous cell carcinoma. 2016 Oct 1
26 27347132 Expression and clinical significance of glucose transporter-1 in pancreatic cancer. 2016 Jul 1
27 25307508 Cancer-specific interruption of glucose metabolism by resveratrol is mediated through inhibition of Akt/GLUT1 axis in ovarian cancer cells. 2015 Dec 1
28 23701133 Relationship between 2-deoxy-2-[(18)F]-fluoro-d-glucose uptake and clinicopathological factors in patients with diffuse large B-cell lymphoma. 2014 Mar 2
29 24365102 Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer. 2014 Feb 4
30 24934577 Significance of 18 F-FDG PET and immunohistochemical GLUT-1 expression for cardiac myxoma. 2014 Jun 16 1
31 23674658 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours. 2013 Aug 1
32 23699745 Glucose transporter-1 distribution in fibrotic lung disease: association with [¹⁸F]-2-fluoro-2-deoxyglucose-PET scan uptake, inflammation, and neovascularization. 2013 Jun 1
33 24045262 Factors affecting 18F-FDG uptake by metastatic lymph nodes in gastric cancer. 2013 Sep-Oct 1
34 24096997 Glucose transporter 3 and 1 may facilitate high uptake of 18F-FDG in gastric schwannoma. 2013 Nov 1
35 26824929 Gene Expression of Glucose Transporter 1 (GLUT1), Hexokinase 1 and Hexokinase 2 in Gastroenteropancreatic Neuroendocrine Tumors: Correlation with F-18-fluorodeoxyglucose Positron Emission Tomography and Cellular Proliferation. 2013 Oct 29 2
36 22398711 Correlation between FDG uptake by PET/CT and the expressions of glucose transporter type 1 and hexokinase II in cervical cancer. 2012 May 1
37 22408261 The pan-deacetylase inhibitor panobinostat induces cell death and synergizes with everolimus in Hodgkin lymphoma cell lines. 2012 Apr 26 2
38 22901702 Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma. 2012 Nov 1
39 20646779 Biologic correlates of ¹⁸F-FDG uptake on PET in pulmonary pleomorphic carcinoma. 2011 Feb 1
40 20884076 Assessment of factors influencing FDG uptake in non-small cell lung cancer on PET/CT by investigating histological differences in expression of glucose transporters 1 and 3 and tumour size. 2011 May 1
41 24899993 Intratumoral Heterogeneous F-18 Fluorodeoxyglucose Uptake Corresponds with Glucose Transporter-1 and Ki-67 Expression in a Case of Krukenberg Tumor: Localization of Intratumoral Hypermetabolic Focus by Fused PET/MR Image. 2011 Jun 1
42 24900002 Impact of Lymphoid Follicles and Histiocytes on the False-Positive FDG Uptake of Lymph Nodes in Non-Small Cell Lung Cancer. 2011 Sep 1
43 20145577 Gene expression and 18FDG uptake in atherosclerotic carotid plaques. 2010 May 2
44 20204293 Use of 18F-fluorodeoxyglucose positron emission tomography for diagnosis of uterine sarcomas. 2010 Apr 1
45 20540786 The association of 18F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients. 2010 Jun 12 1
46 20703861 Correlation between glucose transporter-1 expression and 18F-fluoro-2-deoxyglucose uptake on positron emission tomography in lung cancer. 2010 Aug 1
47 19408578 Relationship between FDG uptake and expressions of glucose transporter type 1, type 3, and hexokinase-II in Reed-Sternberg cells of Hodgkin lymphoma. 2009 1
48 19536037 Glut1 and Glut3 expression in lymphoma and their association with tumor intensity on 18F-fluorodeoxyglucose positron emission tomography. 2009 Aug 1
49 17640764 Adenoid cystic carcinoma of the lung: interest of 18FDG PET/CT in the management of an atypical presentation. 2008 Jan 1
50 17653575 18FDG uptake in oesophageal adenocarcinoma: linking biology and outcome. 2008 Feb 2